Mental disorders are a severe problem of modern society. Significant in these conditions are the striatal-enriched protein tyrosine phosphatase (STEP) (Ptpn5 gene) and the serotonergic system. Nevertheless, the association between them is poorly studied. The aim of this research was to investigate the effects of Ptpn5 gene knockout on behavior and the serotonin system in mice.
Methods
Utilizing the CRISPR/Cas9 system, we cleaved the PTP-domain-encoding sequence from the Ptpn5 gene of C57BL/6 mice. The resulting strain (Ptpn5 KO) demonstrated STEP protein absence and ERK1/2 hyperphosphorylation (STEP substrate) in the brain. We performed behavioral phenotyping, structural magnetic resonance imaging (MRI) and biomolecular screening of the serotonergic system.
Results
Ptpn5 KO mice resembled the wild type in locomotor activity, motor function, and social behavior. They were overactive during dark hours and showed reduced anxiety-related behavior, elevated grooming activity, and an increased pre-pulse inhibition index. Mutant mice performed poorly in the water-related tests. They demonstrated higher immobility time in the forced swim test but not in the analogous dry tail suspension test, and experienced difficulty finding the platform in the Morris water maze but did not fail the novel object recognition test or the operant wall task. Therefore, the observed differences may be a reaction to environmental stress rather than depressive-like behavior or learning deficiency. The Ptpn5 KO strain had a bigger cortex and striatum but a smaller midbrain and cerebellum. Serotonin and its metabolite content was lower in the frontal cortex and higher in the midbrain of Ptpn5 KO mice. A lack of STEP elevated TPH2 protein level in the hippocampus and reduced Htr1a and Htr7 mRNA expression in the midbrain and hippocampus, respectively.
Discussion
The data obtained in this study indicate a significant role of STEP in the regulation of behavior and brain architecture, and highlight the connection between STEP and the 5-HT system.
behaviorbrainmental disordersmicePTPN5serotonin systemstriatal-enriched protein tyrosine phosphatase STEPRussian Science Foundation10.13039/501100006769The author(s) declared financial support was received for this work and/or its publication. This work was supported by Russian Science Foundation project number 25-75-00101. Mice maintenance was supported by the Basic Research Project for a Young Researcher (FWNR-2025-0021) and implemented using the equipment of the Center for Genetic Resources of Laboratory Animals at ICG SB RAS, supported by the Ministry of Education and Science of Russia (Unique identifier of the project RFMEFI62119X0023). DNA sequencing was performed at the SB RAS Genomics Core Facility.section-at-acceptanceMolecular PsychiatryIntroduction
Mental illnesses are the leading cause of disability and life quality deterioration globally. In the last decade, particular attention has been paid to the striatal-enriched protein tyrosine phosphatase (STEP), encoded by the Ptpn5 gene (1). It has been shown that STEP is involved in the pathogenesis of numerous neurodegenerative and psychiatric disorders, as well as in response to stress, brain damage, and aging (for a detailed review, see 2). This derives from STEP’s crucial role in the maintenance of a fragile balance in the nervous cell. STEP dephosphorylates a number of intracellular signaling kinases, such as ERK1/2, Fyn, Pyk2, and p38 (3–6) that are involved in synaptic regulation, neuroplasticity, and cell survival/death determination cascades, as well as glutamate receptor subunits (7, 8) that play a key role in long-term potentiation and depression.
Another prominent player in the pathogenesis of mental disorders is the brain serotonin (5-HT) system. Its dysregulation is considered one of the causes of depression and anxiety disorders (9), obsessive–compulsive disorder (10), and post-traumatic stress disorder (11). The 5-HT system is involved in the control of a great number of physiological processes as well as behavioral and psychological traits. It has been implicated in the coordination of the sleep cycle, sexual behavior, motor control, appetite, and digestion as well as in mood regulation, aggressive behavior, memory, and cognition (for review, see 12). This multifaceted role of 5-HT in the nervous system is in part established by a wide variety of its receptors (13). 5-HT is synthesized from amino acid tryptophan in two stages; the rate-limiting stage is catalyzed in the CNS by the tryptophan hydroxylase 2 (TPH2) enzyme (14). In the synaptic cleft, 5-HT acts via pre- and postsynaptic receptors and is subsequently returned to the 5-HT neuron by the serotonin transporter (5-HTT) (15) where it is metabolized by monoamine oxidase A (MAOA) to 5-hydroxyindolacetic acid (5-HIAA) (16).
Although both STEP and the 5-HT system are involved in a number of mutual processes and diseases, there is a lack of data considering the STEP and 5-HT interplay, despite some indirect evidence of this link. The STEP inhibitor TC-2153 has been shown to act upon several components of the 5-HT system. TC-2153 administration increases levels of 5-HT and its metabolite in the hypothalamus of mice (17), decreases 5-HT2A receptor activity and protein level (18), differentially affects mRNA levels of several 5-HT receptors (19, 20), and alters the enzymatic activity and expression of the main 5-HT system enzymes TPH2 and MAOA (21). Conversely, pharmacological influence on the 5-HT system induces changes in STEP level and activity: acute administration of selective 5-HT reuptake inhibitors increases STEP activity in the brain of zebrafish (22), whereas TPH2 and MAOA inhibitors decrease mouse Ptpn5 gene expression (23) and STEP activity in zebrafish (24).
In addition, experiments with Ptpn5 gene knockout and TC-2153 suggest that STEP plays a significant role in the regulation of spatial learning, dominant behavior (25), prepulse inhibition (26), social memory, stress coping, exploratory activity (27), anxiety (27, 28), depression (18, 29), and aggression (28). There is evidence of 5-HT system involvement in all these processes (9, 12). While Ptpn5 KO mice have been extensively utilized to study the role of STEP in the cellular processes (5–8, 30) and nervous system disorders (7, 31–36), there is a substantial void in the characterization of their 5-HT system, particularly in relation to the observed behavioral phenotype.
To more consistently investigate the crosstalk between STEP and the 5-HT system, we created a mouse strain expressing an inactive STEP protein that lacks the phosphatase domain (Ptpn5 KO mice). In this work, we evaluated the effect of Ptpn5 knockout on behavior, brain region volume, and the 5-HT system in mice.
Materials and methodsGeneration of Ptpn5-KO line
STEP is a protein tyrosine phosphatase; its catalytic domain (PTP-sequence) is located at amino acids positions 470–480 and is encoded in exons 12 and 13. To generate a mouse strain with a functional STEP knockout, we removed the PTP sequence from the Ptpn5 gene using the CRISPR/Cas9 system and applied the previously described approach (37, 38) (Figure 1A).
(A) Scheme of the CRISPR/Cas9 system applied to mouse Ptpn5 gene; (B) amino acid sequence of mouse STEP protein encoded by the Ptpn5 gene. Dark and light gray lettering indicates the exonal structure. Green highlighted sequence is the translation start of the STEP46 isoform and the antigen sequence for the anti-STEP antibody (sc-23892, Santa Cruz Biotechnology, USA). The orange highlighted sequence is absent in the Ptpn5 KO mice. Rectangle shows the phosphatase sequence motif; (C–E) protein quantification by Western blot analysis. (C) STEP protein is absent in the frontal cortex (FC), hippocampus (HC), striatum (ST), and midbrain (MB) of Ptpn5 KO mice. (D, E) STEP substrates ERK1/2 kinases exhibit elevated phosphorylation levels in the striatum of Ptpn5 KO mice. pERK1/2 protein levels were normalized to the amount of GAPDH protein. *p < 0.05, %p = 0.07 compared to the wild type (seven to eight animals per group). Groups were compared with t-test for independent samples.
Figure 1 is a multi-part image detailing the Ptpn5 knockout strategy and protein validation. Panel A shows the CRISPR/Cas9 target sites (sgRNA-12 and sgRNA-13) flanking the phosphatase sequence motif between Exons 12 and 13. Panel B shows the STEP amino acid sequence, identifying the STEP46 isoform start and the sequence absent in KO mice (PTP domain). Panel C shows Western blots confirming the complete absence of all STEP isoforms (STEP61, 46, 38, 33) in the midbrain (MB), hippocampus (HC), frontal cortex (FC), and striatum (ST) of Ptpn5 KO mice, with GAPDH as a loading control. Panels D and E show that pERK2 protein levels are significantly increased in the striatum of Ptpn5 KO mice (p < 0.05).CRISPR system design and preparation of microinjections components
Single guide RNAs (sgRNAs) were designed with the Benchling online tool (https://benchling.com) (Table 1) using the scoring method described previously (39). Genotyping primers were created using the Primer Blast tool (https://www.ncbi.nlm.nih.gov/tools/primer-blast) (Table 1). The sgRNAs were synthetized with the HiScribe™ T7 High Yield RNA Synthesis kit (NEB, Ipswich, MA, USA) and were purified with the RNA Clean & Concentrator-25 kit (Zymo Research, Irvine, CA, USA).
Sequences utilized in the CRISPR system and genotyping primers.
Generation of <italic>Ptpn5</italic> knockout mice
Mice were bred at the SPF animal facility of the Institute of Cytology and Genetics (Novosibirsk, Russia). After weaning, mice of the same sex were kept in groups of four to five animals per cage (Optimice, Animal Care Systems, Centennial, CO, USA). Caging conditions were kept at 24 ± 2°C, 45%–50% humidity, and a 14:10 dark–light cycle (lights on at 01:00; lights off at 15:00). Food and water were provided ad libitum. The food and litter were autoclaved at 121°C before use. Deionized water (produced in a Millipore device) was added with a Severyanka mineral supplement (Eko-proekt, St. Petersburg, Russia).
In vitro fertilization was performed as described earlier (40). Oocytes and spermatozoa were taken from C57BL/6 females (4–6 weeks old) and C57BL/6 males (3 months old), respectively. Oocytes were microinjected with a solution containing 100 ng/μL ssODN (Table 1), 25 ng/μL sgRNA, and an equimolar concentration of Alt-R HiFi Cas9 Nuclease V3 (IDT, Coralville, IA, USA) into the cytoplasm. After the microinjection, embryos were cultivated overnight, and 2-cell stage embryos were transferred into the oviducts of pseudopregnant mothers (females of the CD-1 strain) (41).
Ptpn5-F and Ptpn5-R primers (Table 1) were utilized in the genotyping of the offspring to detect the 347-bp deletion (chr 7:46728942–46729288, GRCm39/mm39). One founder from six founders with the expected deletion was selected for breeding and generating a Ptpn5 knockout strain. The obtained mouse strain was named C57BL/6-Ptpn5_KO (listed in the SPF animal facility of the Institute of Cytology and Genetics catalogue by the name “C57BL/6-Ptpn5-KO-ICG”).
Animals and procedures
Experiments were carried out on adult 2-month-old male mice of the C57BL/6-Ptpn5_KO (Ptpn5 knockout mice) and C57BL/6 (wild type) inbred strains, 24 ± 1 g of weight. In this study, only male mice were used to exclude the influence of the hormonal background on the behavioral tests. Mice were kept in SPF-state conditions as described above. Two days before the tests, the animals were isolated to reduce group effects. Behavioral tests were held between 15:00 and 18:00 in the dark. All procedures were conducted in the strict accordance with the recommendations of the Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes and was approved by the Committee on the Ethics of Animal Experiments of the Russian National Center of Genetic Resources of Laboratory Animals of Institute of Cytology and Genetics of Russian Academy of Sciences (protocol No. 96 of 25 October 2021). All sample sizes were chosen as a compromise between the requirements of statistical correctness and minimization of the number of experimental animals.
Experimental design
Experiment 1. The mice were tested in the marble burying test (MBT) and, on the next day, in the novel object recognition (NOR) test for three subsequent days. Then, the behavior was analyzed for the three subsequent days in the social-interaction test, elevated plus-maze (EPM) test, and three-chambered social approach test. After 1 month of rest, the startle test was performed.
Experiment 2. The behavior of mice was evaluated in the open field (OF) test, in the forced swim test (FST) on the next day, and in the tail suspension test (TST) after 1 day of rest.
Experiment 3. The mice’s performance was assessed in the OF, in the Morris water maze (MWM) on the next 5 days, and in the rotarod test after 2 days of rest. After 1 day of rest, the functional activity of the 5-HT1A receptor was measured; the next day, the functional activity of the 5-HT2A receptor was studied; and after 2 days of rest, the functional activity of the 5-HT7 receptor was evaluated.
Experiment 4. Home cage activity was registered and the operant wall paradigm was carried out over 3 days. Two days later, the animals were euthanized by carbon dioxide asphyxiation followed by decapitation. The frontal cortex, hippocampus, striatum, and midbrain were rapidly dissected, frozen in liquid nitrogen, and stored at −80°C for further assay of monoamine content, TPH2 activity, proteins, and gene expression. The selected brain regions exhibit the most abundant expression of Ptpn5 RNA (1) and are involved in the 5-HT system regulated processes: mood regulation, decision-making, and depressive and anxiety-related behavior; midbrain is home for 5-HT nuclei.
Experiment 5. The brain morphology was studied with magnetic resonance imaging (MRI); total volumes of the whole brain, cortex, striatum, interbrain, hippocampus, pituitary, midbrain, and cerebellum were determined.
Behavioral testingOpen field test
The OF test was carried out to assess the locomotor and exploratory activity. The test took place at the circular arena, 60 cm in diameter (Supplementary Figures S1A, B), as described earlier (42). Movement of the mouse was automatically traced for 5 min with a digital camera. The total distance traveled (m) and time (%) spent in the center of the arena were automatically evaluated by the EthoStudio software (43). The number of vertical postures (rearing) and the number of grooming episodes were marked by experienced rater blinded to the experimental group assignment. After each test, the arena was cleaned with wet (H2O2) and dry napkins.
Forced swim test
In the FST and TST, mice were tested for depressive-like behavior. The FST was performed in a clear, cylindrical glass reservoir (h = 30 cm, d = 15 cm) half filled with water (T = 25°С) and illuminated from beneath. A mouse was carefully placed into the water for 6 min. The first 2 min of the test are adaptive and were not analyzed. For the latter 4 min, the total immobility time was evaluated by an experienced rater, and depressive-like behavior was determined in correspondence to this parameter.
Tail suspension test
A mouse was fixated by the tail with an adhesive tape to a horizontal bar placed 30 cm above the table surface. During the 6 min of the test, immobility episodes, during which a mouse was passive and hung motionless, were recorded by the researcher. Depressive-like behavior was evaluated by the total immobility episodes duration.
Marble burying test
The MBT serves to evaluate the stereotypical behavior associated with obsessive ideas and actions as well as anxiety-related behavior (44). Eighteen identical brightly colored glass marbles (d = 1 cm) were evenly distributed across the clean cage (Optimice, Animal Care Systems, Inc., USA) filled with sawdust layer 4 cm deep. A mouse was placed alone in the cage with marbles for 30 min. Afterwards, the mouse was removed and the number of buried marbles was counted. A marble was considered buried if the sawdust covered over 2/3 of its surface.
Novel object test
The NOR test is utilized to test for the memory performance of mice. We followed the previously described procedure (45). The time spent near the objects was registered automatically. The novelty index was calculated as follows: time spent with new object (No)/[time spent with new object (No) + time spent with familiar object (Fo)] × 100%.
Social interaction test
The test followed the “resident–intruder” paradigm. A juvenile Balb/c male (4 weeks old) was introduced to the home cage of the tested male. During 10 min, social interactions were registered with the EthoStudio software. Social behavior was evaluated as the total duration of social contacts (intruder’s head and body sniffing).
Elevated plus-maze test
The test was carried out in the apparatus made of gray plastic consisting of four arms connected perpendicularly (closed and open, 30 × 6 cm each) with a central area (6 × 6 cm) (Supplementary Figures S2A, B). The closed arms were bordered with 20-cm-high walls. The device was elevated by 60 cm above the floor and dimly illuminated with diffuse lighting (100 lx) of a halogen lamp (25 W) placed under the device. The animal’s movements were automatically traced with a 3D sensor Kinect 1 connected to the PC through a USB-2 port. During the 5 min of testing, the sensor automatically detected the animal’s movement in the open as well as the closed arms. The total path (m), time (%) spent in the center, and open and closed arms were automatically computed by the EthoStudio software. Stretch poses and head dips from the open arms were counted by an experienced rater. The arena was cleaned with wet (H2O2) and dry napkins after each test.
Three-chambered social approach test
To evaluate a mouse’s sociability, a three-chambered social approach test was performed following the protocol described elsewhere (46). During the time of testing, the researcher left the room. Time spent in each chamber was recorded. Movement tracking was performed with Kinect 3D sensor (Microsoft Corporation, USA) connected to the PC through the USB-2 port (47). Time spent in each chamber was evaluated with the EthoStudio software (43). The preference index was calculated as a time (%) spent in the chamber with the “guest” mouse relative to total time. Between tests, the device and all used materials were cleaned with wet (H2O2) and dry napkins.
Rotarod test
To assess balance and motor coordination, mice were tested on a rotor-rod device (San Diego Instruments, USA). A mouse was placed on the rod with a rotation frequency gradually increasing from 5 to 40 rpm within 5 min. The latency time (s) and rotation frequency (rpm) of the mouse’s falling were registered automatically by the device software. For each mouse, the test was repeated three times with 1-min interval. The mean fall latency of the three trials was taken as the final parameter.
Morris water maze
MWM serves to test for spatial learning and memory and was carried out on a software–hardware complex designed in the Institute of Automation and Electrometry SB RAS (Novosibirsk) and adapted for SPF conditions (Supplementary Figures S3A, B) and following a 5-day testing pipeline, described earlier (42). During the acquisition phase for four consecutive days, mice were trained to find the platform. The following parameters were registered automatically: (1) latency time (s): the time for the mouse to find the platform location; (2) path (m) traveled by the animal from the moment it was placed into the water till it found the platform; and (3) cumulative distance (m) between the geometric center of the mouse and the platform. For each day, latency, path, and distance were calculated as the average of the three attempts.
On day 5, the retention test took place. The platform was removed and a mouse was placed at the center of the pool. Results were averaged over the three attempts. A statistically significant excess of the 25% of time spent in the target sector was considered as successful memorizing of the platform’s position.
Startle test
The test was conducted on the SR-Pilot Startle Response System (SR LAB, USA) following a previously described paradigm (48). The test consisted of six sessions, each of which included either a single pulse (P) or a pulse with a prepulse (PP). The magnitude of an acoustic startle response was measured with an accelerometer sensor starting 20 ms after the main signal. The average potential throughout the measurement was taken as the final parameter and prepulse inhibition was calculated as follows: PPI = (AP − APP)/AP × 100%, where AP is the amplitude of the reaction to the pulse and APP is the amplitude of the reaction to the pulse with the prepulse.
Home cage activity
Daily locomotor activity, sleep duration, and food and water consumption were assessed for 72 h with the PhenoMaster device (TSE, Germany) according to the manufacturer’s instruction and as described in detail elsewhere (42). The first 24 h (1–24 h) were considered as adaptive and were not taken into account. Home cage activity of hours 25–72 was analyzed and averaged for one representative 24 h. Locomotor activity is presented as the distance traveled during each hour (m). Sleep data are presented as cumulative sleep duration (min) during each hour. Food and water consumption is displayed as quantity in grams and milliliters, respectively, ingested during every 2 h.
Operant wall
The “operant wall” unit is a metal wall mounted in each individual cage of the PhenoMaster system (TSE, Germany) and is utilized to evaluate associative learning with the previously described paradigm (46). The operant wall was turned on from 15:30 to 17:30 during the mice’s presence in the PhenoMaster-equipped cage. As animals were not subjected to food deprivation, to arouse their interest and familiarize with the reward, a pellet was dispensed without any tasks at habituation day. During the next 3 days, to get the reward, the animal had to perform tasks. To assess the learning capabilities, the total number of received pellets and performed nose pokes were recorded during the task of days 2 and 3.
5-HT receptor functional activityQuantification of 5-HT<sub>1A</sub> receptor functional activity
The functional activity of the 5-HT1A receptor was estimated by quantifying the hypothermic response obtained after acute administration of the 5-HT1A agonist 8-OH-DPAT (1 mg/kg, i.p.) (49, 50). The body temperature was measured by means of a KJT thermocouple (Hanna Instruments, Singapore) with Cooper Constantan Rectal Probes for mice (Physitemp Instruments, Clifton NJ, USA) before the injection and 20 min after drug or saline administration.
Quantification of 5-HT<sub>2A</sub> receptor functional activity
Head twitches in rodents are the main indicator of the activation of the 5-HT2A receptor in vivo (51). A single administration of receptor 5-HT2A agonist DOI (2,5-dimethoxy-4-iodoamphetamine) (1 mg/kg, i.p.) was performed. Five minutes after DOI treatment, head twitches were counted for 20 min.
Quantification of 5-HT<sub>7</sub> receptor functional activity
The functional activity of the 5-HT7 receptor was evaluated as the intensity of the hypothermic response to the selective 5-HT7 agonist LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydro-1-naphthalenyl)-1-piperazinehexanamide hydrochloride) (20.5 nM, i.c.v.) (49). Animals were anesthesized with isoflurane and administered LP44 diluted in sterile water into the left cerebral ventricle (i.c.v.) by microinjection using a stereotaxic instrument (TSE, Germany) at the following coordinates: AP –0.5, L –1.6 mm, DV 2 mm (52). Twenty minutes after injection, the body temperature offset was measured.
Magnetic resonance imaging
The 1H MRI experiment was performed on a horizontal 11.7 T magnet (BioSpec 117/16 USR; Bruker, Germany) as described earlier (53). The brain structures were delineated using the ImageJ software (54) and The Allen Mouse Brain Atlas (55) by an experienced researcher blind to the group assignment (Supplementary Figure S4). Volumes of the brain structures and total volume of the brain were estimated using 23 slices of coronal orientation (slice thickness: 0.5 mm, inter-slice gap: 0 mm) and calculated as a sum of the areas of slices multiplied by 0.5 mm. The areas of structures in each slice were calculated as the number of pixels multiplied by the size of 1 pixel in square millimeters. The volumes of the measured structures were normalized to the total brain volume and are presented as a percentage (%) of the total brain volume.
Biomolecular techniques
Brain structures including the frontal cortex, hippocampus, striatum, and midbrain were homogenized in 300 µL of Tris-HCl buffer (50 mM, pH 7.6) at 4°C using a mechanical homogenizer (Z359971, Sigma-Aldrich, USA). Aliquots of the homogenate were used for 5-HT and 5-HIAA content and TPH2 activity assays with chromatography as well as total RNA and total protein extraction.
5-HT and 5-HIAA content assay
5-HT and 5-HIAA levels were measured in each brain structure with the previously described procedure (56) using a modular chromatographic analysis system (Shimadzu Corporation, USA) equipped with a Luna C18(2) column (5 μm particle size, L × I.D. 100 × 4.6 mm, Phenomenex, USA), a gradient pump (LC-20AD) with a vacuum degasser (DGU-20A5R), an autosampler with a 100-µL loop (SIL-20A), and an electrochemical detector (750 mV, DECADE II, Antec, Netherlands). The 5-HT and 5-HIAA contents were normalized to the amount of total protein measured by means of the Bradford method as described elsewhere (57) and are expressed in nanograms per 1 mg of total protein.
Tryptophan hydroxylase 2 activity assay
TPH2 activity was assessed using the modular chromatographic analysis system described above and following a previously reported method (57). The substrate of the reaction of L-tryptophan was present in the mixture in a concentration of 0.4 mM. Enzymatic activity was calculated as the amount of synthesized 5-hydroxytryptophan (pmol) per minute normalized to the amount of total protein in the sample.
Gene expression quantification with RT-PCR
Total RNA was extracted from the homogenate with the TRIzol Reagent (Life Technologies, USA) according to the manufacturer’s instructions and a previously described protocol (28). On the extracted mRNA, the reverse transcription reaction was performed to synthesize complementary DNA. Gene expression was measured via detection of the fluorescence of the intercalating dye SYBR Green I (R-402 Master Mix, Syntol, Russia). The utilized primers are presented in Table 2. Gene expression was measured using a two-standard method (58–60). As an external standard, a genomic DNA isolated from C57BL/6 male mouse hepatocytes was used (concentrations of 0.06, 0.125, 0.25, 0.5, 1, 2, 4, 8, 16, 32, and 64 ng/µL). A housekeeping gene, Polr2a (encoding a subunit of DNA-dependent RNA polymerase 2), served as an internal standard. Gene expression was evaluated as the number of complementary DNA copies of a target gene per 100 copies of Polr2a.
The sequences of utilized primers, their annealing temperatures, and amplicon lengths.
Gene
Primer sequence
Annealing temperature, °C
Product length, bp
rPol2a
F 5′-tgtgacaactccatacaatgc-3′R 5′-ctctcttagtgaatttgcgtact-3′
60
194
Maoa
F 5′-aatgaggatgttaaatgggtagatgttggt-3′R 5′-cttgacatattcaactagacgctc-3′
64
138
Tph2
F 5′-cattcctcgcacaattccagtcg-3′R 5′-cttgacatattcaactagacgctc-3′
61
239
Htr1a
F 5′-ctgtgacctgtttatcgccctg-3′R 5′-gtagtctatagggtcggtgattgc-3′
62
109
Htr2a
F 5′-agaagccaccttgtgtgtga-3′R 5′-ttgctcattgctgatggact-3′
61
169
Htr7
F 5′-ggctacacgatctactccaccg-3′R5′-cgcacactcttccacctccttc-3′
65
198
Slc6а4
F 5′-cgctctactacctcatctcctcc-3′R 5′-gtcctgggcgaagtagttgg-3′
63
101
Protein quantification with Western blot analysis
For the assessment of protein levels, the homogenate was prepared for Western blot analysis as described earlier (28). The extracts (20 µg per lane) were resolved on a 10% sodium dodecyl sulfate (SDS) polyacrylamide gel and blotted onto a nitrocellulose membrane. The antibody used for target protein detection and the detected protein weights are listed in Table 3. Target protein quantities were normalized to the GAPDH protein level and expressed in relative units.
Antibody utilized in the Western blot analysis, their producers, used dilutions, and targets’ molecular weights.
Antigen
Dilution
Ref. no. and manufacturer
Molecular weight, kDa
STEP
1:1,000 in 5% BSA
sc-23892, Santa Cruz Biotechnology, USA
61, 46, 38, 33
pERK1/2
1:2,000 in 5% milk
Phospho-p44/42 MAPK (Thr202/Tyr204) Antibody #9101, Cell Signaling, USA
42, 44
TPH2
1:1,000 in 5% milk
ab184505, Abcam, UK
56
MAOA
1:500 in 5% milk
ab126751, Abcam, UK
60
5-HT1A
1:500 in 5% milk
ab85615, Abcam, UK
60
5-HT2A
1:1,000 in 5% FBS
sc-15073, Santa Cruz Biotechnology, USA
52
5-HT7
1:1,000 in TBST
ab128892, Abcam, UK
52
5-HTT
1:500 in 5% FBS
303614, US Biological Life Sciences, USA
41
GAPDH
1:2,000 in 5% FBS
ab9485, Abcam, UK
37
Statistical analyses
Home cage behavior monitored parameters: locomotor activity, sleep duration, and food and water consumption were analyzed with repeated-measures ANOVA with factors “Genotype” and “Hour” and are presented as means ± standard deviation (SD) for each hour (locomotor activity and sleep duration) or 2 h (food and water consumption). The Fisher post-hoc analysis was utilized to determine the significance of differences between genotypes for each hour/2 h.
Repeated-measures ANOVA with the Fisher post-hoc analysis was likewise used to analyze the behavior of mice in the learning phase of the MWM test with factors “Genotype” and “Day”. Repeated-measures ANOVA was then performed for each genotype separately with the factor “Day”, followed by the Bonferroni correction, to assess the learning performance of each mouse strain. Test day performance was analyzed with the Student’s t-test vs. the 25% value, subject to the Bonferroni correction.
The rest of the behavioral parameters as well as brain structure volumes, monoamine content, gene expression, protein levels, TPH2 activity, and receptors’ functional activity were tested for normality and equality of dispersion with Lilliefors’ and Barlett’s tests, respectively. Normal and non-normal distributions were then analyzed with the Student’s t-test or Mann–Whitney U-test, respectively. Data are presented as means ± SD.
ResultsGenotyping of the knockout mouse strain
The Ptpn5 gene has four isoforms produced by alternative splicing and their corresponding proteins: STEP61, STEP46, STEP38, and STEP20. Two of these forms, STEP61 and STEP46, contain a PTP sequence required for catalytic activity. C57BL/6-Ptpn5_KO knockout mice were generated using the CRISPR/Cas9 system. As a result, 28 pups were delivered by foster females and genotyped with PCR. Six of them had a deletion of the expected size. Pup #11 was selected as the founder for the generation of the Ptpn5 gene knockout mice; the 347-bp deletion (chr 7:46728942–46729288, GRCm39/mm39) was confirmed by Sanger sequencing. The deleted genomic region consists of 94 bp of the Ptpn5 exon 12 and the complete exon 13 (114 bp) and includes the PTP catalytic domain (Figure 1B). The analysis of the STEP protein level in the striatum using Western blot analysis showed the absence of signal in Ptpn5 mutant mice, indicating a potential STEP protein structure disruption and absence of this protein in knockout mice (Figure 1C).
Mutant STEP protein demonstrates lack of function
STEP46 and STEP61 isoforms dephosphorylate ERK1/2 kinases, thereby modulating several protein signaling pathways in the cell. Western blot analysis revealed an elevated ERK1/2 phosphorylation level in the striatum of Ptpn5 KO mice compared to the wild-type strain, which confirmed the reduction of STEP phosphatase activity in knockout mice (Figures 1D, E). Deletion in the Ptpn5 gene resulted in a significantly higher level of pERK2 protein in the striatum (t14 = 2.25, p < 0.05), while the elevation of pERK1 level was insignificant (t13 = 1.94, p = 0.07).
Behavioral phenotypingHome cage behavior
A significant effect of the Ptpn5 knockout on the home cage behavior was found. Ptpn5 KO mice were more active as indicated by the elevated locomotor activity (genotype effect: F1,14 = 6.64, p < 0.05; genotype × hour interaction: F23,322 = 3.41, p < 0.001) (Figure 2A) and reduced sleep duration (genotype effect: F1,14 = 16.11, p < 0.01; genotype × hour interaction: F23,322 = 2.45, p < 0.001) (Figure 2B). The main differences occurred during the dark phase (active period of mice), between hours 19 and 21 for the distance traveled and between hours 18 and 22 for the cumulative sleep duration. No genotype effect was detected on the average food (F1,14 < 1) (Figure 2C) or water consumption (F1,14 = 1.13, p > 0.05) (Figure 2D). At the same time, the interaction of factors genotype and hour was significant for these parameters (food consumption: F11,154 = 4.38, p < 0.001; water consumption: F11,154 = 4.18, p < 0.001). Nonetheless, no differences for distinct hours were present for water consumption. Food consumption was higher for wild-type mice during hours 15–18 and greater for the Ptpn5 KO mice for the four subsequent hours.
The daily dynamics of (a) locomotor activity (distance run, m) and (b) cumulative sleep duration (min) were continuously measured over each hour; (c) food and (d) water consumption were measured every 2 h in the home cage of the Ptpn5 KO and wild-type mice. The data were averaged over 2 days of monitoring. The X-axis shows day time (h). Black bars under the X-axis highlight the dark phase of the day. Indicated statistical significance refers to the difference between genotypes for the corresponding hour. *p < 0.05, **p < 0.01, ***p < 0.001, #p = 0.059 compared to the wild type (eight animals per group). Groups were compared with repeated-measures ANOVA and Fisher post-hoc analysis for each hour/2 h.
Figure 2 is a set of line graphs showing the hourly dynamics of home cage behavior in Ptpn5 KO versus wild-type mice, averaged over two days. Panel A shows locomotor activity (distance run, m), Panel B shows cumulative sleep duration (min), Panel C shows food consumption (g), and Panel D shows water consumption (ml). The graphs demonstrate that Ptpn5 KO mice have altered circadian patterns, specifically reduced locomotor activity during parts of the dark phase and initial differences in sleep and food consumption compared to wild-type controls. Statistical significance (p < 0.05 to p < 0.001) is indicated at specific time points.Operant wall
Associative learning tested in the “operant wall” paradigm was not affected by the Ptpn5 gene knockout. No effect was detectable for both the number of obtained pellets and the number of nose pokes (Supplementary Table S1).
Open field test
In the OF test, no effects of the Ptpn5 gene knockout were observed on the total distance traveled (locomotor activity), time spent in the center of the arena (Supplementary Figures S1C, D), and the duration of rearing (exploratory activity). Meanwhile, in the knockout mice, the duration of grooming behavior was increased compared to wild-type mice (U = 9, p < 0.05), indicating elevated displacement activity (Supplementary Table S1).
Forced swim test
In the FST, Ptpn5 KO mice demonstrated elevated total immobility time (t12 = 2.59, p < 0.05) (Figure 3A).
Effects of the Ptpn5 gene knockout on behavior of mice in the (a) forced swim test and (b) tail suspension test. *p < 0.05 compared to the wild type (six to eight animals per group). Groups were compared with t-test for independent samples.
Figure 3 is a set of bar charts showing the effect of Ptpn5 knockout on depressive-like behavior. Panel A shows the immobility time (seconds) in the Forced Swim Test (FST). Ptpn5 KO mice exhibit significantly increased immobility time compared to wild-type mice (p < 0.05). Panel B shows immobility time in the Tail Suspension Test (TST), where no significant difference between the two genotypes was observed.Tail suspension test
In the TST, we observed a trend toward a reduction of immobility in the Ptpn5 KO mice compared to wild-type animals (t13 = 2.02, p > 0.05) (Figure 3B).
Marble burying test
In the MBT, Ptpn5 KO mice buried significantly fewer marbles than the wild-type genotype, indicating attenuated stereotypic and anxiety-related behavior (U = 12.5, p < 0.05) (Figure 4).
Effects of the Ptpn5 gene knockout on behavior of mice in the marble burying test. *p < 0.05 compared to the wild type (eight animals per group). Groups were compared with the Mann–Whitney U-test.
Figure 4 is a bar chart comparing the number of marbles buried in the Marble Burying Test (MBT). Ptpn5 KO mice bury significantly fewer marbles compared to the wild-type controls (p < 0.05), indicating altered anxiety-related or compulsive-like behavior.Novel object test
In the NOR test, the total time of contact with the novel object was similar in both strains of mice (Supplementary Table S1).
Social behavior in the social interaction and three-chambered tests
The social behavior of Ptpn5 KO mice did not differ from wild-type mice in the social interaction (Supplementary Table S1) and three-chambered tests (Supplementary Table S1).
Elevated plus-maze test
In the EPM, Ptpn5 KO mice exhibited diminished anxiety-like behavior, spending more time in the open arms (t14 = 2.24, p < 0.05) (Figure 5B) and less time in the closed arms (t14 = 2.41, p < 0.05) (Figure 5C) compared to the wild type (Supplementary Figures S2C, D). Moreover, mice with the mutation showed elevated exploratory activity and risk assessment, as indicated by a higher number of head dips (t14 = 4.09, p < 0.01) (Figure 5D). Meanwhile, no difference between strains was documented in the overall activity (total path traveled) (t13 = 0.86, p > 0.05) (Figure 5A), duration of stretch postures, or time spent in the center of the maze (Supplementary Table S1).
Effects of the Ptpn5 gene knockout in mice on the (a) total path traveled, time spent in the (b) open and (c) closed arms, and (d) duration of head dips in the elevated plus maze test. *p < 0.05, **p < 0.01 compared to the wild type (seven to eight animals per group). Groups were compared with t-test for independent samples.
Figure 5 is a set of bar charts showing the effect of Ptpn5 knockout on various behaviors in the Elevated Plus Maze (EPM). Panel A shows Total Path Traveled (m), which did not differ between groups. Panel B shows Time Spent in Open Arms (%), which is significantly higher in Ptpn5 KO mice (p < 0.05). Panel C shows Time Spent in Closed Arms (%), which is significantly lower in Ptpn5 KO mice (p < 0.05). Panel D shows Duration of Head Dips (seconds), which is significantly higher in Ptpn5 KO mice (p < 0.01). Collectively, the data suggests reduced anxiety in the Ptpn5 KO strain.Rotarod test
No changes in the motor function were observed in the rotarod test, as the latency to fall from the rod was equivalent in both strains of mice (Supplementary Table S1).
Startle test
In the startle response test, the Ptpn5 KO mice displayed a more profound prepulse inhibition evaluated by the average measured potential (t14 = 2.40, p < 0.05) (Figure 6B). The average potential amplitude did not differ between genotypes (t14 = 0.62, p > 0.05) (Figure 6A).
Effects of the Ptpn5 gene knockout on behavior of mice in the startle test. (a) Average potential of pulse and prepulse, (b) prepulse inhibition, calculated as PPI = (P−PP)/P * 100%, where P: reaction to pulse registered as average potential, PP: reaction to pulse with prepulse registered as average potential. *p < 0.05 compared to the wild type (eight animals per group). Groups were compared with t-test for independent samples.
Figure 6 details the sensorimotor gating results from the Startle Test. Panel A is a bar chart showing the Average Potential (mV) of the startle response, which did not significantly differ between Ptpn5 KO and wild-type mice. Panel B is a bar chart showing the Prepulse Inhibition (PPI, %) score. Ptpn5 KO mice exhibit significantly higher PPI compared to wild-type mice (p < 0.05), indicating improved sensorimotor gating.Morris water maze
In the learning phase of the MWM test, we found no effect of the factor Genotype (latency to find the platform: F1,17 = 2.65, p > 0.05; distance traveled: F1,17 = 3.47, p > 0.05; cumulative distance: F1,17 = 1.77, p > 0.05) or the genotype × day interaction on the distance traveled (F3,51 = 1.76, p > 0.05) (Figure 7C). At the same time, there was a significant effect of the factor Day on all of the measured parameters (latency to find the platform: F3,51 = 6.03, p < 0.01; distance traveled: F3,51 = 17.14, p < 0.001; cumulated distance: F3,51 = 6.53, p < 0.001). Moreover, a significant effect of the genotype × day interaction was observed in the cumulative distance (F3,51 = 3.08, p < 0.05), and a trend was noted in the latency to find the platform (F3,51 = 2.66, p = 0.058). Wild-type mice swam closer to the platform with each learning day (F3,21 = 8.41, p < 0.01), whereas no such improvement was detected for the Ptpn5 KO group (F3,27 = 1.61, p > 0.05) (Figure 7B). A similar tendency was observed for the latency to find the platform (wild type: F3,21 = 6.92, p < 0.01; Ptpn5 KO: F3,27 = 1.86, p > 0.05) (Figure 7A, Supplementary Figure S3C, D).
Effects of the Ptpn5 gene knockout on behavior of mice in the (a–c) learning phase and (d) retest session of the Morris water maze. @p < 0.05, p < 0.01, @p < 0.001 compared to Day 1; &p < 0.05, &&p < 0.01,&&&p < 0.001 effect of Day; *p < 0.05 compared to the wild type; ##p < 0.01, ###p < 0.001 compared to 25% (seven to eight animals per group). (a–c) Groups were compared with repeated-measures ANOVA with Fisher post-hoc analysis for each day, (d) groups were compared against 25% with t-test for single means and with each other with t-test for independent samples.
Figure 7 is a set of graphs detailing MWM results. Panels A, B, and C show the daily learning curves for latency to find the platform, distance from the platform, and total path traveled, respectively. Wild-type mice show significant improvement across days, while Ptpn5 KO mice show no significant improvement in the learning curves, with a significant genotype difference on Day 4 for Latency (p < 0.05). Panel D shows the memory retention probe trial (Day 5), where Ptpn5 KO mice spent less time in the target quadrant compared to wild-type controls and the chance level (25%) (p < 0.05).
On the fifth day during the retest session, the spatial memory was assessed. Both strains spent more than 25% of the time in the target area (wild type: t7 = 8.23, p < 0.001; Ptpn5 KO: t10 = 4.44, p < 0.01), which indicates that animals remembered the position of the platform. However, wild-type mice spent more time in the target quadrant of the maze compared to the Ptpn5 KO animals (t17 = 2.37, p < 0.05) (Figure 7D, Supplementary Figure S3E, F).
MRIBrain structure volume
Structural MRI analysis revealed significant differences in the volume of distinct brain regions between wild-type mice and Ptpn5 KO mice. Mutant mice were characterized by a greater volume of the cortex and striatum, whereas the midbrain and cerebellum were smaller in the Ptpn5 KO mice compared to the wild-type animals (Table 4). At the same time, no differences were noticed in the volume of the whole brain, hippocampus, interbrain, and pituitary between the strains (Table 4).
Effects of the Ptpn5 gene knockout on total volumes of brain structures in mice (8–11 animals per group).
Brain structure
Wild type
Ptpn5 KO
Statistical values
Whole brain
476.37 ± 32.52
491.2 ± 29.66
t17 = 1.03, p > 0.05
Cortex
26.94 ± 0.52
27.96 ± 0.76
t17 = 3.28, **p < 0.01
Striatum
8.78 ± 0.32
9.64 ± 0.61
t17 = 3.6, **p < 0.01
Hippocampus
6.61 ± 0.43
6.46 ± 0.32
t17 = 0.89, p > 0.05
Interbrain
8.33 ± 0.84
8.57 ± 1.04
t17 = 0.53, p > 0.05
Midbrain
9.87 ± 1.07
9.02 ± 0.66
t17 = 2.11, *p < 0.05
Cerebellum
13.99 ± 0.91
12.84 ± 1.11
t17 = 2.4, *p < 0.05
Pituitary
0.38 ± 0.08
0.38 ± 0.04
t17 = 0.06, p > 0.05
Whole brain volume is presented in mm3, volumes of other brain regions are presented as % of the whole brain volume. Groups were compared with t-test for independent samples.
Statistically significant differences are highlighted in bold.
Serotonin system5-HT and 5-HIAA levels
Ptpn5 KO mice displayed diminished 5-HT (t14 = 2.87, p < 0.05) (Figure 8A) and (its metabolite) 5-HIAA (t12 = 3.15, p < 0.01) (Figure 8B) levels in the frontal cortex compared to the wild-type mice and elevated levels of these substances in the midbrain (5-HT: t13 = 2.96, p < 0.05; 5-HIAA: t13 = 3.45, p < 0.01) (Figures 8A, B). 5-HT and 5-HIAA content in the striatum was not affected by the Ptpn5 gene knockout (5-HT: t14 = 1.27, p > 0.05; 5-HIAA: t13 = 0.05, p > 0.05) (Figures 8A, B), whereas in the hippocampus, Ptpn5 KO mice showed an increase in the level of 5-HIAA (t13 = 2.69, p < 0.05) (Figure 8B) with unchanged 5-HT content (t14 = 0.41, p > 0.05) (Figure 8A). Meanwhile, no difference between genotypes was documented in the serotonin metabolism index (5-HIAA/5-HT) in any of the investigated brain structures (Supplementary Table S2).
Effects of the Ptpn5 gene knockout on the (a) 5-HT and (b) 5-HIAA levels in the frontal cortex (FC), hippocampus (HC), striatum (ST), and midbrain (MB) of mice, presented as amount of 5-HT or 5-HIAA (ng) per 1 mg of total protein in the probe. *p < 0.05, **p < 0.01 compared to the wild type (seven to eight animals per group). Groups were compared with t-test for independent samples.
Figure 8 is a pair of bar charts showing the effect of Ptpn5 knockout on serotonin and its metabolite levels across four brain regions. Panel A shows 5-HT levels (ng/mg total protein). Levels are significantly diminished in the frontal cortex (FC) (p < 0.05) but elevated in the midbrain (MB) (p < 0.05) of Ptpn5 KO mice. Panel B shows 5-HIAA levels. Levels are diminished in the FC (p < 0.01) and elevated in the hippocampus (HC) and MB (p < 0.05, p < 0.01 respectively).Key enzymes of serotonergic system
Enzymatic activity of TPH2 did not differ between genotypes (Supplementary Table S3). Tph2 gene expression was also not affected by the Ptpn5 gene knockout (Supplementary Table S3). However, we have detected significant differences in the TPH2 protein level in the hippocampus (t13 = 2.97, p < 0.05): Ptpn5 KO mice showed an upregulated level of this protein in this brain region, but not in the frontal cortex, striatum, or midbrain (Figure 9). No significant differences were registered in the Maoa gene expression or MAOA protein levels in either of the investigated brain structures (Supplementary Table S4).
Effects of the Ptpn5 gene knockout on the TPH2 protein level in the frontal cortex (FC), hippocampus (HC), striatum (ST), and midbrain (MB) of mice, presented as the percentage of the GAPDH protein level. *p < 0.05 compared to the wild type (seven to eight animals per group). Groups were compared with t-test for independent samples.
Figure 9 is a bar chart and corresponding Western blots showing TPH2 protein levels (normalized to GAPDH) in four brain regions (FC, HC, ST, MB). TPH2 protein is significantly upregulated specifically in the hippocampus (HC) of Ptpn5 KO mice (p < 0.05), with no significant changes observed in the frontal cortex, striatum, or midbrain.Expression of serotonin transporter
Ptpn5 gene knockout did not affect the serotonin transporter expression in the frontal cortex, hippocampus, midbrain, or striatum (Supplementary Table S5).
Expression and functional activity of 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>7</sub> receptors
Mice with a Ptpn5 gene mutation were characterized by a reduction in Htr1a mRNA level in the midbrain (t12 = 3.36, p < 0.01) (Figure 10A) and by a reduction in Htr7 mRNA level in the hippocampus (t11 = 2.22, p < 0.05) (Figure 10B) compared to the wild type. No differences in Htr2a gene expression were unveiled in all studied structures (Supplementary Table S7). Moreover, no changes in Htr1a gene expression were found in the hippocampus, frontal cortex, and striatum (Figure 10A), as well as in Htr7 mRNA levels in the frontal cortex, midbrain, and striatum (Figure 10B). 5-HT1A, 5-HT2A, and 5-HT7 protein levels and functional activities did not differ between the genotypes (Supplementary Tables S6, S7, and S8).
Effects of the Ptpn5 gene knockout on the (a)Htr1a and (b)Htr7 genes’ expression in the frontal cortex (FC), hippocampus (HC), striatum (ST), and midbrain (MB) of mice, evaluated as the number of transcript copies per 100 copies of Polr2a mRNA. *p < 0.05, **p < 0.01 compared to the wild type (six to eight animals per group). Groups were compared with t-test for independent samples.
Figure 10 is a pair of bar charts showing the effect of Ptpn5 knockout on the mRNA expression of two serotonin receptors. Panel A shows Htr1a mRNA levels, which are significantly reduced in the midbrain (MB) of Ptpn5 KO mice (p < 0.01). Panel B shows Htr7 mRNA levels, which are significantly reduced in the hippocampus (HC) (p < 0.05). No other significant changes were found in the frontal cortex or striatum for either receptor.Discussion
Phosphatase STEP is an important signal transduction protein in the neuron; its functions encompass a wide range of crucial processes, such as the regulation of synaptic function, long-term potentiation and depression, and cell death. Therefore, STEP participates in behavioral control, and its dysregulation is associated with numerous neurodegenerative disorders. It is well-known that the 5-HT system takes part in the regulation of many types of behavioral traits and cognitive processes. However, the association of the serotonergic system and the phosphatase STEP is still poorly studied. In this paper, we aimed to fill this gap using Ptpn5 gene knockout mice generated using the CRISPR/Cas9 system and excising the PTP-domain-encoding sequence. Previously, Ptpn5 KO mice have been created by Venkitaramani et al. (61) utilizing homologous recombination and replacing the PTP-domain sequence with the neomycin cassette, thus adding exogenous genetic material and disrupting the open reading frame. This strain is characterized by behavioral alterations (25, 27), potentially associated with the 5-HT-system. Nevertheless, the 5-HT system changes as well as brain morphology in these mice have not been studied.
The designed mutation was intended to cleave the PTP-domain and produce an inactive STEP form but ultimately resulted in the complete absence of STEP protein. Perhaps, the misfolded structure is detected and destroyed by the cell’s proteasome system. Nonetheless, we succeeded in diminishing STEP activity in the brain, as indicated by the significant upregulation of phosphorylation in STEP substrates (ERK1/2 kinases). The lack of STEP protein caused significant changes in the brain morphology, behavior, and the 5-HT system. At the same time, Ptpn5 KO mice are viable, healthy, fertile, and visually indistinguishable from their wild-type counterparts.
STEP dysfunction significantly affected the volume of several brain regions measured using structural MRI. The cortex and striatum, structures normally rich in Ptpn5 mRNA (1), exhibited excessive growth, whereas midbrain and cerebellum, where Ptpn5 expression is low or undetectable (1), were smaller compared to those of wild-type mice. On the one hand, STEP regulates the membrane localization of glutamate receptors, protecting neural cells from glutamatergic toxicity and overexcitation (62, 63). The absence of STEP in our mice may have disrupted this balance, potentially leading to the hypergrowth of certain structures. On the other hand, STEP also blocks the p38 kinase (64), which regulates apoptosis signaling cascades, and the absence of STEP would lead to the overactivation of this pathway and the elevation of cell death probability and shrinkage of nervous tissue. These results point to the importance of a balance in the STEP-dependent pathways for the development of brain morphology and architecture.
Ptpn5 KO mice, in resemblance to the Ptpn5 KO line previously obtained elsewhere (25, 33), did not demonstrate any alterations in general locomotor activity, motor function, and exploratory or social behavior in a series of behavioral tests. In the home cage, however, Ptpn5 KO mice were more active, had less sleep, and consumed more food between 18:00 and 22:00. The time span of these differences coincides with the end of the operant wall tasks, which took place from 15:30 to 17:30. While no significant differences were found in the task performance, wild-type mice received slightly more pellets on the second day than the Ptpn5 KO mice and, perhaps, were less hungry and less active during the following hours.
Ptpn5 KO mice showed decreased anxiety-like behavior in the EPM test, spending more time in the open arms and less time in the closed arms of the apparatus. While Blázquez and colleagues did not observe any differences in these parameters, their Ptpn5 KO mice exhibited smaller latency to enter the open arms, indicating a slight anxiolytic action of the knockout (27). The anxiolytic effect of STEP inactivation agrees with the studies of the STEP inhibitor benzopentathiepin TC-2153 on mice, rats, and fish (28, 65–67). Furthermore, highly aggressive rats, which have elevated levels of STEP protein in the brain, are characterized by higher anxiety compared to their tame counterparts (28). In the MBT, Ptpn5 KO mice buried significantly less marbles, which, together with decreased stereotypy, can be indicative of lower proneness to anxiety. The MBT is widely used to model autistic-like behavior in rodents (44), and the inhibition of STEP with TC-2153 also attenuates behavioral traits associated with this type of behavior (68). However, in the present study, we did not find any disturbances in social behavior characteristic of the autistic phenotype, so we suppose that the observations in the MBT are rather associated with the general anxiolytic effect of the knockout.
In the startle response test, Ptpn5 KO mice exhibited an elevated pre-pulse inhibition index compared to the wild-type controls. Pre-pulse inhibition deficit is usually associated with schizophrenia (69). Upregulated STEP protein levels have been documented in the pharmacological models of this pathology both in the brains of mice and in the cell cultures (31, 34). A STEP inhibitor alleviated behavioral and molecular abnormalities in these models (31, 34). In the current study, the PPI improvement can possibly be associated with the overdeveloped cortex and striatum (69, 70) and therefore enhanced sensorimotor gating control (71). Of note, hyperactivation of the orbitofrontal cortex–ventromedial striatum system has been reported to increase grooming behavior in mice (72). In the OF test, we revealed elevated displacement activity in Ptpn5 KO mice indicated by more pronounced grooming behavior, which also coincides with previously obtained results (27).
Mutant mice performed poorly in the water-related tests: FST and MWM. In the MWM, Ptpn5 KO mice experienced difficulty finding the platform. In contrast to the control group, the cumulative distance from the platform and the time latency to find the platform did not improve for the Ptpn5 KO mice throughout the learning phase. Meanwhile, the total traveled path did decrease on the 4th day compared to day 1. The observed pattern can indicate an increase of immobility after a long period of being subjected to stressful conditions. In support of this idea, the immobility time in the FST was also prolonged in mutant mice, whereas the analogous but dry TST did not reveal any differences between strains. Therefore, we hypothesize that the observed changes are rather associated with reaction to environmental stress than depressive-like behavior or deficiency in learning ability. On the retest day in the MWM, Ptpn5 KO mice remembered the location of the platform, but still spent less time in the target quarter than the control group, which may also be linked to the immobility reaction to water. At the same time, in the TST (related to depressive-like behavior), the novel object recognition test (memory), and the operant wall task (learning ability), we did not detect any differences between strains.
The above-discussed behavioral traits are, in particular, regulated by the brain 5-HT system (12). Here, we show that Ptpn5 knockout induced changes in different components of this system. First of all, we detected significant alterations in the content of 5-HT and its metabolite in various brain regions. In the midbrain of Ptpn5 KO mice, these substances were upregulated, whereas in the frontal cortex, both were diminished compared to the wild-type mice. In the hippocampus, we observed only a rise in the 5-HIAA level and no changes were found in the striatum. Furthermore, the lack of STEP led to the accumulation of TPH2 protein in the hippocampus of Ptpn5 KO mice. We did not register any differences in the mRNA levels, which could mean that, to the greatest extent, the translation or degradation processes of this protein were affected. The mutation did not alter MAOA or 5-HTT expression, but attenuated the expression of Htr1a gene in the midbrain and Htr7 gene in the hippocampus.
Several mechanisms of Ptpn5 KO that affect the 5-HT system could have taken place. Structural MRI revealed a decrease in total midbrain volume, which is a central brain region for the 5-HT system, and home to the 5-HT nuclei (73). Moreover, we detected lower expression of Htr1a mRNA in this structure. 1A receptors play a crucial role in the 5-HT system autoregulation (74–76); thus, this result can be associated with the observed elevation of serotonin and its metabolite levels in this structure due to the downregulation of presynaptic 1A receptors. STEP inhibitor TC-2153 had the same effect on the Htr1a gene expression after chronic administration to ASC mice (19) and acutely increased both 5-HT and 5-HIAA levels in the hypothalamus of C57BL/6 mice (17).
On the molecular level, the lack of STEP could have induced changes in the 5-HT system through glutamate signaling, the MAPK cascade, or neurotrophic factors. STEP directly dephosphorylates subunits of glutamate receptors (7, 8) and the interplay between these and 5-HT has been documented previously (77, 78). 5-HT receptors of the G protein-coupled receptors family can exert a downstream action on the MAPK pathway (79). Alterations in the functioning of one of the components of this signaling cascade—STEP substrates kinases ERK1/2—could lead to the dysregulation of the feedback signal and receptor desensitization and internalization mechanisms. An observed elevation of TPH2 protein level in the hippocampus of Ptpn5 KO mice with no difference in the Tph2 gene expression and TPH2 enzymatic activity could be explained by the improved protein stability of this enzyme. Although TPH2 does not contain any known tyrosine phosphorylation sites and therefore cannot be directly affected by STEP, its stability is known to be regulated by the serine-19 phosphorylation site (80). One of the key effectors of this site is Ca2+/calmodulin-dependent protein kinase type II (80), whose elevated activity was observed in the synaptosomes purified from Ptpn5 KO mice (30).
The 5-HT system is one of the substantial regulators of anxiety-like behavior. The prefrontal cortex is involved in the top-down control of emotions and behavioral reactions, particularly anxiety (81, 82). Ptpn5 KO mice were characterized by a greater volume of the cortex and a decreased level of 5-HT in the frontal cortex, which is in agreement with decreased anxiety, as this type of behavior has been observed in mice deficient in brain serotonin (83). We have noticed a reduction in Htr7 mRNA levels in the hippocampus of Ptpn5 KO mice, which could also have contributed to the anxiety attenuation since 5-HT7 receptor antagonists are known to produce an anxiolytic effect (84, 85). This interpretation is consistent with our results in aggressive and tame rats: the more anxiety-prone aggressive rats had higher Htr7 mRNA levels in the frontal cortex and hippocampus (20). Meanwhile, we did not detect concomitant changes in the functional activity or protein levels of this receptor, so its role in the observed behavioral alterations is likely not primary. In turn, elevated levels of TPH2 protein in the hippocampus can be associated with the reduction of marble burying behavior of Ptpn5 KO mice, as Tph2 gene knockout mice tend to bury more marbles than the wild type (86).
Several observed 5-HT system peculiarities could have supported the PPI index strengthening in Ptpn5 KO mice. It has been documented that the monoaminergic neurotoxin 5,7-dihydroxytryptamine, which affects 5-HT neurons, leads to PPI disruption (87). The TPH2 inhibitor para-chlorophenylalanine has a similar effect (87). Both these actions correspond to a 5-HT system deficit. The Ptpn5 KO mice, on the other hand, exhibit higher levels of 5-HT in the midbrain and TPH2 protein in the hippocampus and therefore show PPI increase. Furthermore, 5-HT receptors could have taken part in these processes as well. The 5-HT1A receptor agonist 8-OH-DPAT aggravates the PPI index (88, 89), and 5-HT7 antagonists exert a positive action on this parameter in pharmacological schizophrenia models (90, 91). Ptpn5 KO mice showed reduced mRNA expression of these receptors in the midbrain and hippocampus, respectively, which therefore could have had a positive effect on PPI. Once again, we did not observe any differences in the protein levels or receptors’ functional activity; thus, their role is rather suggestive and requires further investigation.
Conclusion
The excision of the PTP-motif-encoding sequence from the mouse Ptpn5 gene resulted in a lack of STEP protein in the brain. It produced noticeable alterations in brain morphology, behavior, and the 5-HT system. These results once again point to the importance of the kinase-phosphatase balance for brain development, behavioral control, and the interplay between mediator systems. Essentially, this study provides a crucial verification of the STEP and 5-HT system interconnection, which offers a new perspective on the role of STEP in the pathogenesis of psychiatric disorders.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
All procedures were conducted in the strict accordance with the recommendations of the Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes and was approved by the Committee on the Ethics of Animal Experiments of the Russian National Center of Genetic Resources of Laboratory Animals of Institute of Cytology and Genetics of Russian Academy of Sciences (protocol No. 96 of 25 October 2021). All sample sizes were chosen as a compromise between the requirements of statistical correctness and minimization of the number of experimental animals.
The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1730197/full#supplementary-material
ReferencesLombrosoPJMurdochGLernerM.
Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum. Proc Natl Acad Sci. (1991) 88:7242–6. doi: 10.1073/pnas.88.16.7242, PMID: 1714595MoskaliukVSKulikovAVNaumenkoVSKulikovaEA.
Current concepts of the role of the STEP striatal-enriched protein tyrosine phosphatase in the pathological and neurodegenerative processes in the brain. Nejrohimiâ. (2024) 41:331–43. doi: 10.31857/S1027813324040042MuñozJJTárregaCBlanco-AparicioCPulidoR.
Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. Biochem J. (2003) 372:193–201. doi: 10.1042/BJ20021941, PMID: 12583813NguyenTHLiuJLombrosoPJ.
Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J Biol Chem. (2002) 277:24274–9. doi: 10.1074/jbc.M111683200, PMID: 11983687PoddarRRajagopalSShuttleworthCWPaulS.
Zn2+-dependent activation of the trk signaling pathway induces phosphorylation of the brain-enriched tyrosine phosphatase STEP: molecular basis for zn2+-induced ERK MAPK activation. J Biol Chem. (2016) 291:813–25. doi: 10.1074/jbc.M115.663468, PMID: 26574547XuJKurupPBartosJAPatriarchiTHellJWLombrosoPJ.
Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity. J Biol Chem. (2012) 287:20942–56. doi: 10.1074/jbc.M112.368654, PMID: 22544749KurupPZhangYXuJVenkitaramaniDVHaroutunianVGreengardP.
A -mediated NMDA receptor endocytosis in alzheimer’s disease involves ubiquitination of the tyrosine phosphatase STEP61. J Neurosci. (2010) 30:5948–57. doi: 10.1523/JNEUROSCI.0157-10.2010, PMID: 20427654ZhangYVenkitaramaniDVGladdingCMZhangYKurupPMolnarE.
The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J Neurosci. (2008) 28:10561–6. doi: 10.1523/JNEUROSCI.2666-08.2008, PMID: 18923032LinJLiuWGuanJCuiJShiRWangL.
Latest updates on the serotonergic system in depression and anxiety. Front Synaptic Neurosci. (2023) 15:1124112. doi: 10.3389/fnsyn.2023.1124112, PMID: 37228487PastreMOccéanB-VBoudousqVConejeroIFabbro-PerayPCollombierL.
Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings. Psychiatry Clin Neurosci. (2025) 79:48–59. doi: 10.1111/pcn.13760, PMID: 39511769DavisLLSurisALambertMTHeimbergCPettyF.
Post-traumatic stress disorder and serotonin: New directions for research and treatment. J Psychiatry Neuroscience: JPN. (1997) 22:318–26.
Bacqué-CazenaveJBharatiyaRBarrièreGDelbecqueJ-PBouguiyoudNDi GiovanniG.
Serotonin in animal cognition and behavior. Int J Mol Sci. (2020) 21:1649. doi: 10.3390/ijms21051649, PMID: 32121267HoyerDClarkeDEFozardJRHartigPRMartinGRMylecharaneEJ.
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. (1994) 46:157–203. doi: 10.1016/S0031-6997(25)06783-3IchiyamaANakamuraSNishizukaYHayaishiO.
Enzymic studies on the biosynthesis of serotonin in mammalian brain. J Of Biologwal Chem. (1970) 245:1699–709. doi: 10.1016/S0021-9258(19)77149-XBlakelyRDBersonHEFremeauRTCaronMGPeekMMPrinceHK.
Cloning and expression of a functional serotonin transporter from rat brain. Nature. (1991) 354:66–70. doi: 10.1038/354066a0, PMID: 1944572FitzgeraldLWKaplinskyLKimelbergHK.
Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J Neurochemistry. (1990) 55:2008–14. doi: 10.1111/j.1471-4159.1990.tb05789.x, PMID: 1700071KulikovaEABazhenovaEYPopovaNKKhomenkoTMVolchoKPSalakhutdinovNF.
Effect of acute administration of 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153) on biogenic amines metabolism in mouse brain. Lett Drug Design Discov. (2015) 12:833–6. doi: 10.2174/1570180812666150522221634KulikovaEAKhotskinNVIllarionovaNBSorokinIEBazhenovaEYKondaurovaEM.
Inhibitor of striatal-enriched protein tyrosine phosphatase, (TC-2153), produces antidepressant-like effect and decreases functional activity and protein Level of 5-HT2A receptor in the brain. Neuroscience. (2018) 394:220–31. doi: 10.1016/j.neuroscience.2018.10.031, PMID: 30367948KulikovAVTikhonovaMAKulikovaEAKhomenkoTMKorchaginaDVVolchoKP.
Effect of new potential psychotropic drug, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride, on the expression of serotonin-related genes in mouse brain. Molekuliarnaia Biologiia. (2011) 45:282–8. doi: 10.1134/S0026893310061044, PMID: 21634115MoskaliukVSKozhemyakinaRVKhomenkoTMVolchoKPSalakhutdinovNFKulikovAV.
On associations between fear-induced aggression, bdnf transcripts, and serotonin receptors in the brains of Norway rats: an influence of antiaggressive drug TC-2153. Int J Mol Sci. (2023) 24:983. doi: 10.3390/ijms24020983, PMID: 36674499MoskaliukVSKozhemyakinaRVKhomenkoTMVolchoKPSalakhutdinovNFKulikovAV.
Key enzymes of the serotonergic system - tryptophan hydroxylase 2 and monoamine oxidase A - in the brain of rats selectively bred for a reaction toward humans: effects of benzopentathiepin TC-2153. Biochem Biokhimiia. (2024) 89:1109–21. doi: 10.1134/S0006297924060105, PMID: 38981704KulikovaEABazovkinaDVEvsyukovaVSKulikovAV.
Acute administration of imipramine and citalopram increases activity of striatal-enriched tyrosine protein phosphatase (STEP) in brain of zebrafish danio rerio. Bull Exp Biol Med. (2021) 170:627–30. doi: 10.1007/s10517-021-05120-8, PMID: 33788115KulikovaEAFursenkoDVBazhenovaEKulikovAV.
Pargyline and р-chlorophenylalanine decrease expression of ptpn5 encoding striatal-enriched protein tyrosine phosphatase (STEP) in the mouse striatum. Mol Biol. (2020) 54:274–80. doi: 10.1134/S0026893320020090KulikovaEAFursenkoDVBazhenovaEKulikovAV.
Decrease in the Activity of Striatal-Enriched Protein-Tyrosine-Phosphatase (STEP) in the Brain of Danio rerio Treated with p-Chlorophenylalanine and Pargyline. Mol Biol. (2021) 55:604–9. doi: 10.1134/S0026893321020254, PMID: 34432783VenkitaramaniDVMouraPJPicciottoMRLombrosoPJ.
Striatal-enriched protein tyrosine phosphatase (STEP) knockout mice have enhanced hippocampal memory: Behavioral plasticity in STEP knockout mice. Eur J Neurosci. (2011) 33:2288–98. doi: 10.1111/j.1460-9568.2011.07687.x, PMID: 21501258Sukoff RizzoSJLotarskiSMStolyarPMcNallyTArturiCRoosM.
Behavioral characterization of striatal-enriched protein tyrosine phosphatase (STEP) knockout mice. Genes Brain Behav. (2014) 13:643–52. doi: 10.1111/gbb.12169, PMID: 25103464BlázquezGCastañéASaavedraAMasanaMAlberchJPérez-NavarroE.
Social memory and social patterns alterations in the absence of STriatal-enriched protein tyrosine phosphatase. Front Behav Neurosci. (2018) 12:317. doi: 10.3389/fnbeh.2018.00317, PMID: 30760987MoskaliukVSKozhemyakinaRVBazovkinaDVTereninaEKhomenkoTMVolchoKP.
On an association between fear-induced aggression and striatal-enriched protein tyrosine phosphatase (STEP) in the brain of Norway rats. Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie. (2022) 147:112667. doi: 10.1016/j.biopha.2022.112667, PMID: 35104695KulikovAVTikhonovaMAKulikovaEAVolchoKPKhomenkoTMSalakhutdinovNF.
Antidepressant activity of 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin- 6-amine hydrochloride (TC-2153): comparison with classical antidepressants. Lett Drug Design Discov. (2014) 11:169–73. doi: 10.2174/15701808113106660079BoscoFValentePMilaneseMPicciniAMessaMBonannoG.
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice. Mol Neurobiol. (2018) 55:8084–102. doi: 10.1007/s12035-018-0980-5, PMID: 29508281CartyNCXuJKurupPBrouilletteJGoebel-GoodySMAustinDR.
The tyrosine phosphatase STEP: Implications in schizophrenia and the molecular mechanism underlying antipsychotic medications. Trans Psychiatry. (2012) 2:e137–7. doi: 10.1038/tp.2012.63, PMID: 22781170DebIManhasNPoddarRRajagopalSAllanAMLombrosoPJ.
Neuroprotective role of a brain-enriched tyrosine phosphatase, STEP, in focal cerebral ischemia. J Neurosci. (2013) 33:17814–26. doi: 10.1523/JNEUROSCI.2346-12.2013, PMID: 24198371Goebel-GoodySMWilson-WallisEDRoystonSTagliatelaSMNaegeleJRLombrosoPJ.
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Genes Brain Behav. (2012) 11:586–600. doi: 10.1111/j.1601-183X.2012.00781.x, PMID: 22405502XuJKurupPBaguleyTDFoscueEEllmanJANairnAC.
Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice. Cell Mol Life Sci. (2016) 73:1503–14. doi: 10.1007/s00018-015-2057-1, PMID: 26450419XuJHartleyBJKurupPPhillipsATopolAXuM.
Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models. Mol Psychiatry. (2018) 23:271–81. doi: 10.1038/mp.2016.163, PMID: 27752082ZhangYKurupPXuJAndersonGMGreengardPNairnAC.
Reduced levels of the tyrosine phosphatase STEP block β amyloid-mediated GluA1/GluA2 receptor internalization. J Neurochemistry. (2011) 119:664–72. doi: 10.1111/j.1471-4159.2011.07450.x, PMID: 21883219BattulinNKovalzonVMKorablevASerovaIKiryukhinaOOPechkovaMG.
Pannexin 1 transgenic mice: human diseases and sleep-wake function revision. Int J Mol Sci. (2021) 22:5269. doi: 10.3390/ijms22105269, PMID: 34067798KorablevANSerovaIASerovOL.
Generation of megabase-scale deletions, inversions and duplications involving the Contactin-6 gene in mice by CRISPR/Cas9 technology. BMC Genet. (2017) 18:112. doi: 10.1186/s12863-017-0582-7, PMID: 29297312HsuPDScottDAWeinsteinJARanFAKonermannSAgarwalaV.
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. (2013) 31:827–32. doi: 10.1038/nbt.2647, PMID: 23873081TakeoTNakagataN.
In vitro fertilization in mice. Cold Spring Harbor Protoc. (2018) 2018. doi: 10.1101/pdb.prot094524, PMID: 29669849KorablevANSerovaIASkryabinBV.
Manipulations with early mouse embryos for generation of genetically modified animals. Vavilov J Genet Breed. (2017) 21:758–63. doi: 10.18699/VJ17.291KhotskinNVPlyusninaAVKulikovaEABazhenovaEYFursenkoDVSorokinIE.
On association of the lethal yellow (A) mutation in the agouti gene with the alterations in mouse brain and behavior. Behav Brain Res. (2019) 359:446–56. doi: 10.1016/j.bbr.2018.11.013, PMID: 30447239KulikovAVTikhonovaMAKulikovVA.
Automated measurement of spatial preference in the open field test with transmitted lighting. J Neurosci Methods. (2008) 170:345–51. doi: 10.1016/j.jneumeth.2008.01.024, PMID: 18342949DeaconRMJ.
Digging and marble burying in mice: Simple methods for in vivo identification of biological impacts. Nat Protoc. (2006) 1:122–4. doi: 10.1038/nprot.2006.20, PMID: 17406223AbdullinaAAVasilevaEVKulikovaEANaumenkoVSPlyusninaAVGudashevaTA.
The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex. J Psychopharmacol (Oxford England). (2022) 36:214–22. doi: 10.1177/02698811211069101, PMID: 35102783KondaurovaEMBelokopytovaIIKulikovaEAKhotskinNVIlchibaevaTVTsybkoAS.
On the role of serotonin 5-HT1A receptor in autistic-like behavior: Сross talk of 5-HT and BDNF systems. Behav Brain Res. (2023) 438:114168. doi: 10.1016/j.bbr.2022.114168, PMID: 36280010KulikovVAKhotskinNVNikitinSVLankinVSKulikovAVTrapezovOV.
Application of 3-D imaging sensor for tracking minipigs in the open field test. J Neurosci Methods. (2014) 235:219–25. doi: 10.1016/j.jneumeth.2014.07.012, PMID: 25066208KulikovAVKorostinaVSKulikovaEAFursenkoDVAkulovAEMoshkinMP.
Knockout Zbtb33 gene results in an increased locomotion, exploration and pre-pulse inhibition in mice. Behav Brain Res. (2016) 297:76–83. doi: 10.1016/j.bbr.2015.10.003, PMID: 26454239NaumenkoVSKondaurovaEMPopovaNK.
On the role of brain 5-HT7 receptor in the mechanism of hypothermia: Comparison with hypothermia mediated via 5-HT1A and 5-HT3 receptor. Neuropharmacology. (2011) 61:1360–5. doi: 10.1016/j.neuropharm.2011.08.022, PMID: 21884711OverstreetDHRezvaniAHKnappDJCrewsFTJanowskyDS.
Further selection of rat lines differing in 5-HT-1A receptor sensitivity: Behavioral and functional correlates. Psychiatr Genet. (1996) 6:107–17. doi: 10.1097/00041444-199623000-00002, PMID: 8902886GreenARHealDJ.
The effects of drugs on serotonin-mediated behavioural models. Neuropharmacology Serotonin. (1985), 326–65.
SlotnickBMLeonardCM. A stereotaxic atlas of the albino mouse forebrain. Rockville, Md:
Alcohol, Drug Abuse, and Mental Health Administration : Washington (1975).
KulikovaEABazovkinaDVAkulovAETsybkoASFursenkoDVKulikovAV.
Alterations in pharmacological and behavioural responses in recombinant mouse line with an increased predisposition to catalepsy: Role of the 5-HT1A receptor. Br J Pharmacol. (2016) 173:2147–61. doi: 10.1111/bph.13484, PMID: 27004983SchneiderCARasbandWSEliceiriKW.
NIH Image to ImageJ: 25 years of image analysis. Nat Methods. (2012) 9:671–5. doi: 10.1038/nmeth.2089, PMID: 22930834LeinESHawrylyczMJAoNAyresMBensingerABernardA.
Genome-wide atlas of gene expression in the adult mouse brain. Nature. (2007) 445:168–76. doi: 10.1038/nature05453, PMID: 17151600KhotskinNVKomlevaPDArefievaABMoskaliukVSKhotskinaAAlhalabiG.
The C1473G mutation in the mouse tph2 gene: from molecular mechanism to biological consequences. Biomolecules. (2025) 15:461. doi: 10.3390/biom15040461, PMID: 40305154KomlevaPDAlhalabiGIzyurovAEKhotskinNVKulikovAV.
Effects of the combination of the C1473G mutation in the tph2 gene and lethal yellow mutations in the raly-agouti locus on behavior, brain 5-HT and melanocortin systems in mice. Biomolecules. (2023) 13:963. doi: 10.3390/biom13060963, PMID: 37371543KulikovAVNaumenkoVSVoronovaIPTikhonovaMAPopovaNK.
Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard. J Neurosci Methods. (2005) 141:97–101. doi: 10.1016/j.jneumeth.2004.06.005, PMID: 15585293NaumenkoVSOsipovaDVKostinaEVKulikovAV.
Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J Neurosci Methods. (2008) 170:197–203. doi: 10.1016/j.jneumeth.2008.01.008, PMID: 18308402NaumenkoVSKulikovAV.
Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Molekuliarnaia Biologiia. (2006) 40:37–44. doi: 10.1134/s0026893306010079, PMID: 16523690VenkitaramaniDVPaulSZhangYKurupPDingLTresslerL.
Knockout of STriatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation. Synapse. (2009) 63:69–81. doi: 10.1002/syn.20608, PMID: 18932218BraithwaiteSPPaulSNairnACLombrosoPJ.
Synaptic plasticity: One STEP at a time. Trends Neurosci. (2006) 29:452–8. doi: 10.1016/j.tins.2006.06.007, PMID: 16806510XuJKurupPZhangYGoebel-GoodySMWuPHHawasliAH.
Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J Neuroscience: Off J Soc Neurosci. (2009) 29:9330–43. doi: 10.1523/JNEUROSCI.2212-09.2009, PMID: 19625523PoddarRDebIMukherjeeSPaulS.
NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell death: Role of STEP in neuronal survival and death. J Neurochemistry. (2010) 115:1350–62. doi: 10.1111/j.1471-4159.2010.07035.x, PMID: 21029094KhomenkoTMTolstikovaTGBolkunovAVDolgikhMPPavlovaAVKorchaginaDV.
8-(Trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine: novel aminobenzopentathiepine having in vivo anticonvulsant and anxiolytic activities. Lett Drug Design Discov. (2009) 6:464–7. doi: 10.2174/157018009789057544KulikovASinyakovaNKulikovaEKhomenkoTSalakhutdinovNKulikovV.
Effects of acute and chronic treatment of novel psychotropic drug, 8- (Trifluoromethyl)-1, 2, 3, 4, 5-benzopentathiepin-6-amine hydrochloride (TC-2153), on the behavior of zebrafish (Danio rerio): A comparison with fluoxetine. Lett Drug Design Discov. (2019) 16:1321–8. doi: 10.2174/1570180816666190221162952SinyakovaNAKulikovaEAEnglevskiiNAKulikovAV.
Effects of fluoxetine and potential antidepressant 8-trifluoromethyl 1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153) on behavior of danio rerio fish in the novel tank test and brain content of biogenic amines and their metabolites. Bull Exp Biol Med. (2018) 164:620–3. doi: 10.1007/s10517-018-4045-6, PMID: 29577201ChatterjeeMSinghPXuJLombrosoPJKurupPK.
Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism. Behav Brain Res. (2020) 391:112713. doi: 10.1016/j.bbr.2020.112713, PMID: 32461127BraffDLGeyerMASwerdlowNR.
Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology. (2001) 156:234–58. doi: 10.1007/s002130100810, PMID: 11549226SchwabeKKochM.
Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats. Neurosci Lett. (2004) 355:5–8. doi: 10.1016/j.neulet.2003.10.028, PMID: 14729221Jaaro-PeledHKumarSHughesDSumitomoAKimS-HZoubovskyS.
Regulation of sensorimotor gating via Disc1/Huntingtin-mediated Bdnf transport in the cortico-striatal circuit. Mol Psychiatry. (2022) 27:1805–15. doi: 10.1038/s41380-021-01389-3, PMID: 35165396AhmariSESpellmanTDouglassNLKheirbekMASimpsonHBDeisserothK.
Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science. (2013) 340:1234–9. doi: 10.1126/science.1234733, PMID: 23744948DahlstroemAFuxeK.
Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiologica Scandinavica. Supplementum. (1964) 232:1–55., PMID: 14229500HjorthSSharpT.
Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. (1991) 48:1779–86. doi: 10.1016/0024-3205(91)90216-x, PMID: 1826937MellerEGoldsteinMBohmakerK.
Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: Possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol. (1990) 37:231–7. doi: 10.1016/S0026-895X(25)09962-6, PMID: 1968223VergeDDavalGPateyAGozlanHel MestikawySHamonM.
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol. (1985) 113:463–4. doi: 10.1016/0014-2999(85)90099-8, PMID: 2931289González-MaesoJAngRLYuenTChanPWeisstaubNVLópez-GiménezJF.
Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature. (2008) 452:93–7. doi: 10.1038/nature06612, PMID: 18297054HealyDJMeador-WoodruffJH.
Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain. Neuropsychopharmacology: Off Publ Am Coll Neuropsychopharmacol. (1999) 21:341–51. doi: 10.1016/S0893-133X(99)00043-3, PMID: 10457531LiebmannC.
Regulation of MAP kinase activity by peptide receptor signalling pathway: Paradigms of multiplicity. Cell Signalling. (2001) 13:777–85. doi: 10.1016/s0898-6568(01)00192-9, PMID: 11583913KuhnDMSakowskiSAGeddesTJWilkersonCHaycockJW. Phosphorylation and activation of tryptophan hydroxylase 2: Identification of serine-19 as the substrate site for calcium, calmodulin-dependent protein kinase II.
Journal of Neurochemistry, Wiley. (2007). pp. 1567–73. doi: 10.1111/j.1471-4159.2007.04855.x., PMID: 17727633BourasNNMackNRGaoW-J.
Prefrontal modulation of anxiety through a lens of noradrenergic signaling. Front Syst Neurosci. (2023) 17:1173326. doi: 10.3389/fnsys.2023.1173326, PMID: 37139472KenwoodMMKalinNHBarbasH.
The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacology: Off Publ Am Coll Neuropsychopharmacol. (2022) 47:260–75. doi: 10.1038/s41386-021-01109-z, PMID: 34400783MosienkoVBertBBeisDMatthesSFinkHBaderM.
Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Trans Psychiatry. (2012) 2:e122–2. doi: 10.1038/tp.2012.44, PMID: 22832966PytkaKPartykaAJastrzębska-WięsekMSiwekAGłuch-LutwinMMordylB.
Antidepressant- and anxiolytic-like effects of new dual 5-HT1A and 5-HT7 antagonists in animal models. PloS One. (2015) 10:e0142499. doi: 10.1371/journal.pone.0142499, PMID: 26554929WesołowskaANikiforukAStachowiczKTatarczyńskaE.
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology. (2006) 51:578–86. doi: 10.1016/j.neuropharm.2006.04.017, PMID: 16828124SavelievaKVZhaoSPogorelovVMRajanIYangQCullinanE.
Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PloS One. (2008) 3:e3301. doi: 10.1371/journal.pone.0003301, PMID: 18923670FletcherPJSelhiZFAzampanahASillsTL.
Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Neuropsychopharmacology: Off Publ Am Coll Neuropsychopharmacol. (2001) 24:399–409. doi: 10.1016/S0893-133X(00)00215-3, PMID: 11182535RigdonGCWeatherspoonJK.
5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther. (1992) 263:486–93. doi: 10.1016/S0022-3565(25)10375-3, PMID: 1432685SipesTAGeyerMA.
8-OH-DPAT disruption of prepulse inhibition in rats: Reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology. (1995) 117:41–8. doi: 10.1007/BF02245096, PMID: 7724701GaliciRBoggsJDMillerKLBonaventurePAtackJR.
Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Behav Pharmacol. (2008) 19:153–9. doi: 10.1097/FBP.0b013e3282f62d8c, PMID: 18332680NikiforukAKosTFijałKHołujMRafaDPopikP.
Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PloS One. (2013) 8:e66695. doi: 10.1371/journal.pone.0066695, PMID: 23776692
Edited by: George Uhl, VA Maryland Healthcare System, United States
Reviewed by: A. J. Baucum, Indiana University Bloomington, United States
Weiwei Cui, Southern Medical University, China
5-HIAA, 5-Hydroxyindolacetic acid; 5-HT, Serotonin; 5-HT1A, Serotonin receptor of type 1A; 5-HT2A, Serotonin receptor of type 2A; 5-HT7, Serotonin receptor of type 7; 5-HTT, Serotonin transporter; ANOVA, Analysis of variance; EPM, Elevated plus-maze test; ERK, Extracellular regulated kinase; FST, Forced swim test; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; Htr1a, Gene encoding 5-HT1A; Htr2a, Gene encoding 5-HT2A; Htr7, Gene encoding 5-HT7; MAOA, Monoamine oxidase A; MAPK, Mitogen-activated protein kinase; MBT, Marble burying test; MWM, Morris water maze; NOR, Novel object recognition test; OF, Open field test; PTP, Protein tyrosine phosphatase; Ptpn5, Gene encoding STEP; Slc6a4, Gene encoding 5-HTT; SPF, Special pathogen free; STEP, Striatal-enriched protein tyrosine phosphatase; TPH2, Tryptophan hydroxylase 2; TST, Tail suspension test.